APPEALS COURT REVIVED A $6.7 BILLION LAWSUIT AGAINST BRISTOL MYERS SQUIBB OVER DELAYED DRUG APPROVALS - QZ

$6.7B liability revived by appeals court, a major regulatory setback for Bristol Myers Squibb.